Christopher Edwards | Academic Influence

Why Is Christopher Edwards Influential?

According to Wikipedia, Sir Christopher Richard Watkin Edwards is a former Vice-Chancellor of Newcastle University. Career Educated at Marlborough College and Christ's College, Cambridge, Edwards became senior lecturer in medicine at St Bartholomew's Hospital in London in 1975, Professor of Medicine at the University of Edinburgh in 1980 and Dean of the Faculty of Medicine at the University of Edinburgh in 1991. He was appointed the first Principal of the Imperial College School of Medicine in 1995 before becoming Vice-Chancellor of Newcastle University in 2001.

(See a Problem?)

Christopher Edwards 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. (1998) (3525)
IDH mutation impairs histone demethylation and results in a block to cell differentiation (2012) (1673)
LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR (1988) (1093)
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. (1997) (901)
Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? (1993) (575)
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (1996) (454)
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. (1988) (442)
Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. (1996) (432)
Characterization of mutations in patients with multiple endocrine neoplasia type 1. (1998) (426)
HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOGUE IN NORMAL MAN (1978) (362)
Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. (1996) (356)
11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. (1995) (328)
Licorice inhibits corticosteroid 11 beta-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. (1989) (315)
Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine (1972) (307)
Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. (1995) (307)
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. (1999) (299)
Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform. (1993) (290)
11 beta-hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. (1990) (222)
Release of Oxytocin and Vasopressin by the Human Foetus during Labour (1971) (220)
Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2. (1996) (203)
Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man. (1990) (199)
Deficient inactivation of cortisol by 11β‐hydroxysteroid dehydrogenase in essential hypertension (1993) (189)
The hypothalamic-pituitary-adrenal axis. (1983) (175)
11β-Hydroxysteroid dehydrogenases: Key enzymes in determining tissue-specific glucocorticoid effects (1996) (172)
Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess. (1994) (154)
Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. (1979) (154)
11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. (1991) (154)
Functional localization of single active ion channels on the surface of a living cell (2000) (150)
Cell volume measurement using scanning ion conductance microscopy. (2000) (150)
Dynamic assembly of surface structures in living cells (2003) (149)
Metyrapone in long-term management of Cushing's disease. (1977) (144)
Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory Studies (1973) (133)
Circulating human pituitary pro-γ-melanotropin enhances the adrenal response to ACTH (1981) (132)
Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. (1992) (126)
Regulation of 11 beta-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. (1993) (126)
11β-hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulated (1998) (122)
Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. (1994) (121)
'Liver-type' 11 beta-hydroxysteroid dehydrogenase cDNA encodes reductase but not dehydrogenase activity in intact mammalian COS-7 cells. (1994) (119)
Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid (1990) (117)
CYCLICAL COMBINATION CHEMOTHERAPY AND GONADAL FUNCTION (1979) (116)
Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. (1996) (113)
Amenorrhoea, Galactorrhoea, and Primary Hypothyroidism with High Circulating Levels of Prolactin (1971) (110)
Ion channels in small cells and subcellular structures can be studied with a smart patch-clamp system. (2002) (109)
11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism. (1996) (104)
Cutaneous vasoconstrictor response to glucocorticoids in asthma (1991) (101)
Tissue-specific distribution of the NAD(+)-dependent isoform of 11 beta-hydroxysteroid dehydrogenase. (1992) (98)
INHIBITION OF THE PLASMA-ALDOSTERONE RESPONSE TO FRUSEMIDE BY BROMOCRIPTINE (1975) (91)
The development and application of a direct radioimmunoassay for plasma aldosterone using 125I-labeled ligand--comparison of three methods. (1978) (85)
Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris (1982) (80)
Male gonadal function in coeliac disease: 2. Sex hormones. (1983) (79)
Male gonadal function in coeliac disease: 1. Sexual dysfunction, infertility, and semen quality (1982) (79)
Recessive inheritance of diabetes: the syndrome of diabetes insipidus, diabetes mellitus, optic atrophy and deafness. (1976) (75)
Hypothalamic-pituitary-gonadal function in men with cirrhosis of the liver. (1976) (75)
The use of scanning ion conductance microscopy to image A6 cells (2004) (73)
Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA (1995) (73)
The development and application of a direct radioimmunoassay for corticosterone (1981) (71)
Pregnancy in patients presenting with hyperprolactinaemia. (1979) (70)
Water and electrolyte balance in subjects with a permanent ileostomy. (1983) (69)
Glucocorticoids Regulate Hippocampal 11β‐Hydroxysteroid Dehydrogenase Activity and Gene Expression in vivo in the Rat (1994) (69)
Hybrid scanning ion conductance and scanning near-field optical microscopy for the study of living cells. (2000) (69)
IN VIVO AND IN VITRO STUDIES ON THE EFFECT OF METOCLOPRAMIDE ON ALDOSTERONE SECRETION (1980) (63)
Plasma Prolactin Activity in Inappropriate Lactation (1971) (62)
Late-Onset Apparent Mineralocorticoid Excess Caused by Novel Compound Heterozygous Mutations in the HSD11B2 Gene (2003) (62)
Ovarian 11β-hydroxysteroid dehydrogenase: potential predictor of conception by in-vitro fertilisation and embryo transfer (1993) (61)
Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene. (1992) (60)
Rat liver 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. (1993) (59)
LLC-PK1 cells model 11 beta-hydroxysteroid dehydrogenase type 2 regulation of glucocorticoid access to renal mineralocorticoid receptors. (1995) (56)
5 alpha-reductase activity in polycystic ovary syndrome. (1990) (55)
Aldosterone acts via an ATP autocrine/paracrine system: the Edelman ATP hypothesis revisited. (2005) (55)
CAPTOPRIL: REVERSIBLE RENAL FAILURE WITH SEVERE HYPERKALÆMIA (1980) (55)
Ontogeny of 11 beta-hydroxysteroid dehydrogenase in rat brain and kidney. (1992) (55)
Mutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. (1994) (54)
Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. (1981) (53)
Novel method for rapid toxicity screening of magnetic nanoparticles (2018) (52)
Ambulatory Blood Pressure Is Associated With Polymorphic Variation in P2X Receptor Genes (2008) (52)
11 beta-Hydroxysteroid dehydrogenase in the rat ovary: high expression in the oocyte. (1992) (51)
Purification of 11 beta-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique. (1996) (48)
Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+ channel activity in renal epithelia. (2007) (47)
ENDOCRINE FUNCTION IN THE PRADER‐WILLI SYNDROME (1980) (46)
Diseases of the hypothalamus and pituitary gland. (1974) (45)
Apparent mineralocorticoid excess. (1994) (44)
Human gamma-melanotropin precursor potentiates corticotropin-induced adrenal steroidogenesis by stimulating mRNA synthesis. (1982) (43)
Congenital and acquired syndromes of apparent mineralocorticoid excess (1993) (41)
11Beta‐Hydroxysteroid Dehydrogenase Messenger Ribonucleic Acid Expression, Bioactivity and Immunoreactivity in Rat Cerebellum (1990) (41)
11-Beta-hydroxysteroid dehydrogenase activity and gene expression in the hypertensive Bianchi—Milan rat (1993) (39)
A radioimmunoassay for 18-hydroxycortisol in plasma and urine. (1985) (39)
The 11 beta-hydroxysteroid dehydrogenase inhibitor glycyrrhetinic acid affects corticosteroid feedback regulation of hypothalamic corticotrophin-releasing peptides in rats. (1993) (38)
Steroid metabolism determines mineralocorticoid specificity in the toad bladder. (1989) (37)
Corrigendum: Clinical studies of multiple endocrine neoplasia type 1 (MEN1) (Q J Med (1996) 89 (653-659)) (1996) (35)
The cortisol-cortisone shuttle and the apparent specificity of glucocorticoid and mineralocorticoid receptors (1991) (34)
CLINICAL EXPERIENCE WITH 75Se SELENOMETHYLCHOLESTEROL ADRENAL IMAGING (1981) (34)
Lessons from licorice. (1991) (33)
Testosterone metabolism by the rat gastrointestinal tract, in vitro and in vivo. (1982) (33)
Clonidine therapy for Shapiro's syndrome. (1992) (32)
Relation of plasma aldosterone concentration to diuretic treatment in patients with severe heart disease. (1979) (32)
Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis. (1983) (31)
The effect of testosterone replacement on plasma lipids and apolipoproteins (1989) (31)
Normal Growth Hormone Response to the 75 g Oral Glucose Tolerance Test Measured by Immunoradiometric Assay (1989) (30)
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 (1997) (30)
THE ENDOCRINE AND METABOLIC EFFECTS OF CIMETIDINE (1983) (30)
Adrenal synthesis of corticosterone in response to ACTH in rats is influenced by leukotriene A4 and by lipoxygenase intermediates. (1987) (29)
Linkage analysis of 7 polymorphic markers at chromosome 11p11. 2‐11q13 in 27 multiple endocrine neoplasia type 1 families (1993) (29)
Progesterone, prolactin, and gynaecomastia in men with liver disease. (1982) (29)
Diurnal variation of plasma corticosterone in depression (1990) (29)
11β-Hydroxysteroid Dehydrogenase and Its Inhibitors in Hypertensive Pregnancy (1995) (29)
Scanning ion conductance microscopy reveals how a functional renal epithelial monolayer maintains its integrity. (2005) (29)
Genetic Disorders of the Endocrine Glands (1972) (28)
Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta (1994) (28)
A direct radioimmunoassay for 11-deoxycortisol (1982) (27)
Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase in hypertension. (1995) (26)
In vitro and in vivo Electrochemical Measurement of ROS After Treatment with Anticancer Drugs. (2020) (26)
Regulation of 11 beta-hydroxysteroid dehydrogenase activity by the hypothalamic-pituitary-adrenal axis in the rat. (1994) (26)
Use of an enzyme linked immunosorbent assay (ELISA) for quantification of proteins on the surface of materials. (1988) (25)
Alcohol inhibits 11-beta-hydroxysteroid dehydrogenase activity in rat kidney and liver. (1995) (25)
Optimization of a direct radioimmunoassay for plasma aldosterone. (1981) (24)
The cortisol-cortisone shuttle and hypertension (1991) (23)
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies (1982) (23)
An in vitro stimulatory effect of indoleamines on aldosterone biosynthesis in the rat. (1982) (23)
THE EFFECT OF CYPROTERONE ACETATE ON SERUM TESTOSTERONE, LH, FSH, AND PROLACTIN IN MALE SEXUAL OFFENDERS (1980) (23)
The development of a radioimmunoassay for arginine-vasopressin: production of antisera and labelled hormone; separation techniques; specificity and sensitivity of the assay in aqueous solution. (1972) (22)
Relation between adenosinetriphosphate activity and sarcomere length in stretched glycerol-extracted frog skeletal muscle. (1965) (22)
The specificity of the human mineralocorticoid receptor: clinical clues to a biological conundrum. (1989) (22)
New mechanisms for corticosteroid-induced hypertension. (1994) (22)
INCREASED PLASMA RENIN ACTIVITY IN TYPE 1 DIABETES WITH MICROVASCULAR DISEASE (1982) (21)
Development and application of a simple radioimmunoassay for urinary aldosterone. (1981) (21)
Renal 11-beta-hydroxysteroid dehydrogenase: a mechanism ensuring mineralocorticoid specificity. (1990) (21)
Liquorice (1991) (21)
Intravenous captopril treatment in patients with severe cardiac failure. (1986) (21)
HUMAN PROLACTIN, ITS ISOLATION, ASSAY AND CLINICAL APPLICATIONS (1972) (20)
Donnan potential of rabbit skeletal muscle myofibrils I: electrofluorochromometric detection of potential. (1975) (20)
Hypothalamic syndrome and central sleep apnoea associated with toluene exposure. (1991) (20)
Prolactinoma: a question of rational treatment. (1981) (20)
Vasopressin and oxytocin in health and disease. (1977) (20)
THYROID HORMONES AND THE REGULATION OF THYROID FUNCTION IN MEN WITH COELIAC DISEASE (1982) (19)
Ambulatory Blood Pressure Is Associated With Polymorphic Variation in P 2 X Receptor Genes (2008) (19)
Evaluation and application of magnetizable charcoal for separation in radioimmunoassays. (1979) (19)
Development and optimisation of a radioimmunoassay for plasma captopril. (1983) (19)
Endocrine Function in the Prader-Willi Syndrome (1978) (18)
The sensitivity of human blood platelets to the aggregating agent ADP during different dietary sodium intakes in healthy men (1992) (18)
Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma. (1987) (17)
Hypertension in mice caused by inactivation of 11 beta-hydroxysteroid dehydrogenase type 2 (1998) (17)
11 beta-Hydroxysteroid dehydrogenase mRNA expression in rat kidney. (1991) (16)
The effects of ranitidine on pituitary hormone secretion in vitro. (1980) (16)
Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure. (1985) (16)
Development and application of a direct radioimmunoassay for aldosterone in saliva (1985) (15)
Autoimmune progesterone dermatitis (case report) (1990) (15)
SUBTRACTION POTENTIAL DIFFERENCE: IN-VIVO ASSAY FOR MINERALOCORTICOID ACTIVITY (1978) (15)
8 Increased vasoconstriction to glucocorticoids in essential hypertension: 11??-hydroxysteroid dehydrogenase deficiency revisited (1991) (15)
131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre. (1988) (15)
Circulating human pituitary pro-gamma-melanotropin enhances the adrenal response to ACTH. (1981) (14)
The production and assessment of monoclonal antibodies to cortisol (1985) (14)
Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure. (1991) (13)
Changes in total body calcium following surgery for primary hyperparathyroidism. (1986) (13)
High sodium intake increases platelet aggregation in normal females. (1987) (13)
Blood pressure, renin-angiotensin-aldosterone axis and cortisol changes during withdrawal from alcohol. (1989) (13)
Evaluation of the mineralocorticoid activity of 18-hydroxycorticosterone. (1981) (13)
Polytome-encephalography in the investigation of pituitary tumours. (1971) (12)
The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa. (1984) (12)
Cerebral vasospasm following subarachnoid hemorrhage: effect of calcitonin gene-related peptide on middle cerebral artery velocities using transcranial Doppler sonography. (1991) (12)
Glycyrrhetinic acid and potentiation of hydrocortisone activity in skin (1990) (12)
Production of high affinity monoclonal antibodies to deoxycorticosterone. (1984) (12)
Adrenalectomy does not influence basal secretion of testosterone in rat in vivo. (1989) (12)
Ovarian 11 beta-hydroxysteroid dehydrogenase: potential predictor of conception by in-vitro fertilisation and embryo transfer. (1993) (12)
FACTORS IN THE CONTROL OF PLASMA RENIN ACTIVITY AND CONCENTRATION IN TYPE 1 (INSULIN‐DEPENDENT) DIABETES (1984) (12)
11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action. (1996) (12)
LETTERS to the EDITORLiquorice (1991) (12)
Endocrine and Metabolic Disease (1988) (12)
17β-hydroxysteroid dehydrogenase activity in the mucosa of rat and human small intestine (1981) (11)
Sex hormone changes underlying menstrual disturbances on haemodialysis. (1978) (11)
The development of a radioimmunoassay and a plasma extraction method for vasopressin. (1970) (11)
Effect of increased potassium concentrations on particle motion within a neurosecretory structure. (1977) (11)
Protein Intake in Pregnancy, Placental Glucocorticoid the Programming of Hypertension in the Rat Metabolism and (1996) (10)
In vitro studies on the effects of ranitidine on isolated anterior pituitary and adrenal cells. (1981) (10)
The adrenal gland and progesterone stimulates testicular steroidogenesis in the rat in vivo. (1989) (9)
The effect of sodium intake on the renin response to dopamine in superfused rat renal cortical cells. (1985) (9)
Studies on the cryoactivaqtion of human renin (1981) (9)
Primary mineralocorticoid excess syndromes (2006) (9)
Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol. (1987) (9)
Mapping mechanical properties of living cells at nanoscale using intrinsic nanopipette-sample force interactions. (2021) (8)
Measurement of Plasma and Urinary Vasopressin by Immunoassay (1971) (8)
Mithramycin treatment of malignant hypercalcaemia. (1968) (8)
Dexamethasone-suppressible Hypertension (1993) (8)
Essential hypertension as an endocrine disease (1985) (8)
Serotonin stimulates calcium influx in isolated rat adrenal zona glomerulosa cells. (1991) (7)
Application of a novel radioimmunoassay for serotonin in the detection of aromatic l-amino acid decarboxylase activity in isolated renal cortical cells (1989) (7)
Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment. (1994) (7)
Human 3 beta-hydroxysteroid dehydrogenase: genes and phenotypes. (1996) (7)
Autonomic neural control mechanisms and the release of adrenal steroids after hypoglycaemia in man. (2008) (7)
Cellular selectivity of aldosterone action: role of 11 beta-hydroxysteroid dehydrogenase. (1995) (6)
In Vitro/In Vivo Electrochemical Detection of Pt(II) Species. (2022) (6)
A Rational Approach in Assessing the Need for Corticosteroid Replacement Therapy (1988) (6)
Magnetisable solid-phase separation fluoroimmunoassay for total oestriol in pregnancy serum. (1981) (6)
17 beta-Hydroxysteroid dehydrogenase activity in the mucosa of rat and human small intestine. (1981) (6)
Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations. (1992) (6)
The influence of posture on the response to loop diuretics in patients with chronic cardiac failure is reduced by angiotensin converting enzyme inhibition (2004) (6)
EFFECT OF ADRENALECTOMY AND DEXAMETHASONE ADMINISTRATION ON 11BETA -HYDROXYSTEROID DEHYDROGENASE IN VITRO ACTIVITY IN RAT BRAIN AND KIDNEY (1991) (6)
Proceedings: The development of radioimmunoassays for 18-hydroxycorticosterone and 18-hydroxy-11-deoxycorticosterone. (1974) (6)
The adrenal secretion of progesterone stimulates testicular steroidogenesis in the rat in vitro. (1985) (6)
University of Dundee Hypertension in mice lacking 11 beta-hydroxysteroid dehydrogenase type 2 (1999) (5)
Dual effect of etomidate on mineralocorticoid biosynthesis. (1988) (5)
Reversible pituitary stalk enlargement in cranial diabetes insipidus. (1991) (5)
Studies on the cryoactivation of human renin. (1981) (5)
Hyperandrogenism in polycystic ovary syndrome. (1994) (5)
Development and application of a superfusion technique for the study of renin secretion in rat renal cortical cells. (1986) (5)
The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure. (1992) (4)
Serotoninergic stimulation of aldosterone secretion in the rat in vivo: role of the renin-angiotensin system. (1991) (4)
Improved 125I-ligands for gentamicin radioimmunoassay. (1979) (4)
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure. (1991) (4)
11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy. (1995) (4)
Serum lipoproteins and the concentrations of thyroxine and sex hormones in diabetic man. (1980) (4)
Comparison of plasma immunoreactive and bioactive corticotrophin [proceedings]. (1977) (3)
17 Liquorice Induced Mineralocorticoid Excess: 11 ??- Hydroxysteroid Dehydrogenase Deficiency Comes of Age (1987) (3)
Novel Control Mechanisms of Aldosterone Secretion (1983) (3)
Treatment of porphyria cutanea tarda in renal failure with ultra-low-dose chloroquine (1990) (2)
5α-reductase and polycystic ovaries (1990) (2)
11 beta-Hydroxysteroid dehydrogenase activity in hypertension and renal disease. (1993) (2)
A125I-Based Radioimmunoassay for Serum Gentamicin (1976) (2)
Nanopipette biosensors as a new tool for metabolism and signaling investigation (2017) (2)
11-BETA-HYDROXYSTEROID DEHYDROGENASE MESSENGER-RNA EXPRESSION IN RAT-KIDNEY (1991) (2)
Traditional Methods of Follow-Up for Thyroid Disease—in Descent? (1984) (1)
18 Blood pressure and birth weight: is fetal glucocorticoid exposure the missing link? (1992) (1)
Premenstrual exacerbation of atopic dermatitis: autoimmune progesterone dermatitis? (1990) (1)
Lack of correlation between the acute haemodynamic response to intravenous captopril and plasma concentrations of angiotensin II in patients with chronic cardiac failure (2005) (1)
Androgen and Gonadotrophin Disturbance in Male Patients with Liver Disease (1975) (1)
A lack of effect of captopril on platelet aggregation in patients with congestive heart failure (2004) (1)
Hirsuties and virilism (1972) (1)
The Thyroid Gland (1988) (1)
Non-synonymous polymorphism in the coding sequence of human 3-beta hydroxysteroid dehydrogenase (HSD3B). (1991) (1)
Hypermineralocorticoidism due to abnormal metabolism of cortisol (1994) (1)
23. A direct magnetic solid-phase radioimmunoassay for plasma aldosterone (1978) (1)
Development and application of an automated direct radioimmunoassay for plasma aldosterone [proceedings]. (1979) (1)
Effects of two different angiotensin II antagonists on aldosterone secretion by isolated perfused rat zona glomerulosa cells. (1981) (1)
Prevalence of Primary Aldosteronism (1982) (1)
Effects of the K+ channel activator BRL 34915 on aldosterone secretion in isolated rat zona glomerulosa cells (1989) (1)
Cell stiffness and ROS level alterations in living neurons mediated by β-amyloid oligomers measured by scanning ion-conductance microscopy. (2021) (1)
In vitro/ In vivo Electrochemical Detection of Pt(II) Species (2021) (1)
Scanning ion-conductance microscopy for studying β-amyloid aggregate formation on living cell surface (2022) (1)
High-resolution Label-free 3D Mapping of metabolites of Single Living Cells (2020) (1)
CORRELATIVE QUANTITATIVE NANOMECHANICAL MAPPING AND CONFOCAL IMAGING OF LIVING CELLS BY SCANNING ION-CONDUCTANCE MICROSCOPY (2021) (0)
Galactorrhoea. (1972) (0)
Inhibition of 11 beta hydroxysteroid dehydrogenase 11 beta ohsd in skin enhances topical hydrocortisone activity (1990) (0)
Regulation des concentrations de glucocorticoides intracellulaires (1996) (0)
The Adrenal Gland (1988) (0)
The stability of tritiated serotonin stored at 4 degrees C--implications for platelet uptake studies. (1988) (0)
Aldosteronism in Patients with a Permanent Ileostomy (1982) (0)
13 Dexamethasone treatment of pregnant rats leads to raised blood pressure in the offspring (1992) (0)
Reports of Societies (1982) (0)
Virilizing Ovarian Tumour and Polycystic Ovary Syndrome (1972) (0)
Metabolism of the Peripheral Vasodilator, Fiosequinam in Human Liver in Vitro (1990) (0)
Hypertension-Old Riddle: New Clues (1982) (0)
DEMONSTRATION OF SPECIFIC 5HT2 RECEPTORS IN THE ADRENAL ZONA GLOMERULOSA USING KETANSERIN, A SPECIFIC 5HT2 RECEPTOR ANTAGONIST. (1983) (0)
Effect of therapeutic agents on tumor cell compartments studied by local measurement of cell stiffness via Scanning Ion-Conductance Microscopy (2019) (0)
An Improved Radioimmunoassay for Serotonin (1986) (0)
200. Plasma levels of 18-OH-corticosterone in normal subjects: effects of sodium intake, ACTH and metyrapone administration (1978) (0)
Development and application of a direct radioimmunoassay for plasma aldosterone [proceedings]. (1978) (0)
SCANNOING ION CONDUCTANCE MICROSCOPY AS A NEW METHOD FOR NANOPARTICLE RESEARCH (2018) (0)
Large-scale tissue culture for human IFN-beta production. (1981) (0)
subjects with a permanent ileostomy . Water and electrolyte balance in (2006) (0)
Parathyroid Glands, Calcium and Bone Metabolism (1988) (0)
The Pituitary Gland (1988) (0)
Fundamentals of Clinical Endocrinology (1974) (0)
Thyroid Disease and Muscle Dysfunction (1975) (0)
Waterandelectrolyte balance insubjects with a permanent ileostomy (1983) (0)
Chapter 11 Enzyme modulation of access to corticosteroid receptors (1997) (0)
Drug-induced alterations in cancer cell compartments studied by local stiffness measurement via scanning ion-conductance microscopy (2019) (0)
20. An abnormality in cortisol metabolism in patients with renal disease (1988) (0)
Endogenous Hormone Concentrations and Serum Lipoproteins in Male Diabetic Subjects (1978) (0)
The Endocrine Pancreas (1988) (0)
Polytome Encephalography in Investigation of Pituitary Tumours [Abstract] (1970) (0)
Book Review: Thyroid Disease and Muscle Dysfunction (1975) (0)
University of Dundee Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2 Kotelevtsev, (1999) (0)
Defective Post-Translational Cleavage of Pro-Opiocortin in Cushing's Disease (1982) (0)
Scanning ion-conductance microscopy technique for studying the topography and mechanical properties of Candida parapsilosis yeast microorganisms. (2022) (0)
Novel method for rapid toxicity screening of magnetic nanoparticles (2018) (0)
A new in vitro screening system for evaluating of anticancer drugs effect (2019) (0)
Scanning Ion Conductance Microscopy for Single Cell Analysis (2020) (0)
Nanopipette navigation system as a new tool for nanoscale investigation of living cells (2018) (0)
PI3K-Mediated Epithelial Sodium Channel Activity by Regulating the Apical Membrane Morphology of Renal Epithelial Cells (2008) (0)
Inhibition of the renin-angiotensin-aldosterone axis by low dose intravenous captopril as a treatment for accelerated phase hypertension. (1985) (0)
CYPROTERONE ACETATE (1976) (0)
Malegonadal function incoeliac disease: 2.Sexhormones (1983) (0)
18-Hydroxycortisol stimulation in isolated guinea pig adrenocortical cells parallels that of both aldosterone and cortisol. (1992) (0)
The medical treatment of adrenal disease. (1989) (0)
Book Review: Genetic Disorders of the Endocrine Glands (1972) (0)
News Release (1987) (0)
Nanoscale bio-imaging with scanning ion conductance microscopy (2019) (0)
Intravenous captopril treatmentinpatients with severecardiac failure (1986) (0)
Hypertestosteronaemia: A Reversible Abnormality in Men with Coeliac Disease (1977) (0)
Book Review: Fundamentals of Clinical Endocrinology (1974) (0)

This paper list is powered by the following services:

Other Resources About Christopher Edwards

What Schools Are Affiliated With Christopher Edwards ?

Christopher Edwards is affiliated with the following schools: